APA ציטוט

Yogev, R., Kovacs, A., Chadwick, E. G., Homans, J. D., Lou, Y., & Symonds, W. T. (2005). Single-Dose Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, in HIV-Infected Children. American Society for Microbiology.

Citação norma Chicago

Yogev, Ram, Andrea Kovacs, Ellen G. Chadwick, James D. Homans, Yu Lou, and William T. Symonds. Single-Dose Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, in HIV-Infected Children. American Society for Microbiology, 2005.

ציטוט MLA

Yogev, Ram, et al. Single-Dose Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, in HIV-Infected Children. American Society for Microbiology, 2005.